Psychometric validation of the Dysphagia Symptom Questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Funding for this research was provided by:
Endpoint Outcomes was funded by Meritage Pharma Inc., now part of the Shire group of companies, to conduct the analysis.
unspecified valid from 2017-09-12